Logo

Guardant Health

Korean AI Pathology Startup Lunit Nabs $26M Investment from Guardant Health; Plans Collaboration

Having closed a Series C funding round, the firm is completing clinical validation, and will collaborate with Guardant to develop new precision oncology products.

Guardant Health Targets Emerging Treatment Response Market With New ctDNA Product
Premium

The firm announced the new test, Guardant360 Response, alongside its launch of its Guardant360 TissueNext tumor tissue genomic profiling product.

GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April

The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.

FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen

The approval makes Lumakras the first inhibitor of KRAS, once considered "undruggable," to reach the market for KRAS-mutated NSCLC.

Guardant Health Sues Natera for False Advertising, 'Misleading' Oncologists About MRD Tests

Guardant has asked the court to recover damages and to prevent Natera from further disseminating "deceptive" advertising regarding their competing assays.

May 21, 2021

Guardant Health to License IP to Foundation Medicine for $25M, Royalties Under Settlement Agreement

May 21, 2021

FDA Approves Janssen's Rybrevant, Guardant360 CDx for EGFR Exon 20-Mutated NSCLC

May 7, 2021

Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape
Premium

May 6, 2021

Guardant Health Q1 Revenues up 17 Percent

Apr 14, 2021

Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries

Apr 1, 2021

Guardant Health Receives New York State Approval for Guardant Reveal MRD Test

Mar 2, 2021

Guardant360 CDx Receives CE Mark for Tumor Mutational Profiling and Tagrisso CDx Use

Feb 26, 2021

Guardant Health Begins First Foray Into Early-Stage Cancer With Commercial MRD Test Launch
Premium

Feb 24, 2021

Guardant Health Q4 Revenues Up 25 Percent

Feb 19, 2021

New Products Posted to GenomeWeb: Guardant Health, Parse Biosciences, Menarini Silicon Biosystems

Feb 5, 2021

Guardant Health Turns to Tumor Tissue Sequencing to Broaden Offering
Premium

Jan 12, 2021

JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher

Dec 18, 2020

People in the News: New Appointments at Fluidigm, Danaher, Guardant Health

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Nov 17, 2020

Guardant Health Prices $1B Senior Notes Offering

Nov 5, 2020

Guardant Health Q3 Revenues Up 23 Percent

Nov 2, 2020

Regulatory Documents for Newly Approved Liquid Biopsy NGS Panels Detail Diverse Test Claims, Methods
Premium

Oct 5, 2020

Guardant Health Liquid Biopsy Test Improves Gastrointestinal Cancer Clinical Trial Enrollment

Aug 24, 2020

Guardant Health Receives FDA Emergency Use Authorization for COVID-19 Sequencing Test

Aug 24, 2020

Streck Gets FDA De Novo Clearance for Blood Collection Tube With Guardant Health Liquid Biopsy Assay

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.